The Endocrine Society condemns the Florida Medical Commission’s decision to ban gender-affirming care for transgender and gender-diverse teenagers.
We call on the Florida Medical Commission to rescind the ban and allow physicians to provide evidence-based care and save the lives of minors.
The ban in Florida is blatantly discriminatory and contradicts medical evidence followed by the Endocrine Society, American Academy of Pediatrics, American Medical Association, American Psychological Association, Pediatric Endocrinology Society, and other mainstream medical organizations.
When a person’s gender identity is not respected and medical care is not accessible, psychological problems may be scored higher and the risk of suicide and other self-harm may be increased. Research shows that denying access to drugs that delay puberty and hormone therapy increases the risk of suicidal ideation and self-harm.
According to the Endocrine Society’s globally recognized evidence-based clinical practice guidelines, only reversible treatments to delay puberty are recommended for adolescents. Drugs that delay puberty are safe, reversible, and a conservative approach that gives teens and their families more time to consider their options.The same treatments have been used for decades to treat precocious puberty. It’s been done.
Teenagers who continue to demonstrate gender discord and demonstrate the ability to provide informed consent can be offered partially reversible gender-confirming hormone therapy. The Florida Medicaid ban will prevent teens from accessing these important treatment options.
Medical evidence, not politics, should inform treatment decisions. While the Endocrine Society submitted comments earlier this year during an abbreviated public comment period on the commission’s guidance on “Treatment of Gender Dysphoria in Children and Adolescents,” the Florida Board of Health said it was criticized by the mainstream medical community. It chose to rely on unrecognized and controversial research. As a result, the state blocked transgender residents from receiving gender-affirming care through Medicaid coverage.
According to Freedom for All Americans, 20 states have proposed legislation to limit access to healthcare in 2022. The Endocrine Society warns that misinformation about health care recommendations for transgender and gender-diverse adolescents is fueling efforts to limit access to gender-affirming care. . The Florida Health Commission’s move to ban gender-affirming care based on political agendas rather than science sets a dangerous precedent for all healthcare decisions.